Physiological Role
Insulin is a peptide hormone produced by the beta cells of the pancreas, within the islets of Langerhans. Its central function is to regulate blood glucose levels. It facilitates glucose entry into muscle, liver, and adipose cells, where it serves as energy or is stored as glycogen.
Beyond glucose metabolism, insulin participates in muscle protein synthesis and lipid metabolism regulation. It also plays a role in cellular signaling, through pathways involved in growth and proliferation. Its role is therefore cross-cutting: it influences body composition, energy storage, and overall metabolic homeostasis.
In the fasting state, circulating levels reflect the background demand imposed by tissues. This baseline is a direct mirror of insulin sensitivity. When cells become less receptive, the pancreas increases its output to maintain blood glucose. This phenomenon, insulin resistance, constitutes a central lever of metabolic aging.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
Fasting insulin values in the optimal zone indicate preserved tissue sensitivity. The pancreas produces just enough to maintain blood glucose, without overproduction. This is the profile that asks the least of the pancreas over time.
Elevated values signal that the body requires more insulin to accomplish the same task. This compensatory mechanism, hyperinsulinemia, often precedes any visible change in blood glucose or HbA1c by several years. It is an early signal of insulin resistance.
Low values may reflect reduced pancreatic production or high insulin sensitivity. In the context of longevity, the Leiden Longevity Study is illuminating. Offspring of nonagenarian families show a lower average fasting insulin than their partners living in the same household.
Fasting insulin reading gains its full dimension when combined with fasting glucose and HbA1c. The HOMA-IR index, calculated from these first two markers, refines the understanding of insulin sensitivity.
Influencing Factors
Diet. Refined carbohydrates and added sugars trigger postprandial insulin spikes. A diet rich in fiber, protein, and quality fats stabilizes the insulin response. The order in which foods are consumed within a meal also influences spike amplitude.
Physical activity. Exercise improves insulin sensitivity by stimulating muscular glucose uptake. Zone 2 training and resistance training are the most documented modalities for this effect. Ten minutes of walking after a meal is sufficient to attenuate the insulin response.
Body composition. Visceral adiposity is a major factor in insulin resistance. A reduction in abdominal fat improves tissue sensitivity.
Sleep. Sleep deprivation reduces insulin sensitivity within 48 hours. Chronic sleep loss is associated with basal hyperinsulinemia.
Chronobiology. Insulin sensitivity follows a circadian rhythm, peaking in the morning. The eating window and its alignment with the circadian cycle influence the overall insulin response.
Stress. Chronically elevated cortisol increases insulin resistance by stimulating hepatic gluconeogenesis and reducing insulin efficiency at the muscular level.
In the Singular Formula
Fasting insulin is one of the glycemic markers integrated into the Singular formulation engine. Its role is twofold: metabolic monitoring parameter and trigger for nutritional adjustments.
When fasting insulin sits in the high or very high zone, the engine raises taurine dosage to its reinforced level and delivers dietary guidance content. Fasting glucose, HbA1c and HOMA-IR trigger the same rule, each independently. A separate safety rule, commanded by elevated HOMA-IR alone, removes glucosamine sulfate from the formula.
The formula also includes magnesium, omega-3 (EPA+DHA) and vitamin D3. None of these three bioactives is adjusted in response to fasting insulin.
Fasting insulin is also one of the two components of HOMA-IR, an index calculated by Singular from insulin and fasting glucose. This complementarity allows the formulation engine to cross-reference three levels of glucose metabolism reading.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Paolisso G et al. | 1996 | Cohort Study | American Journal of Physiology | View on PubMed |
Glucose tolerance and insulin action in healthy centenarians Study of 14 healthy Italian centenarians. Compared with older subjects, they retain preserved glucose tolerance and insulin action, measured with the euglycemic clamp. The study addresses insulin effectiveness, not its concentration. | ||||
| Zhang X. et al. | 2017 | Meta-analysis | Bioscience Reports | View on PubMed |
Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis Meta-analysis of 7 studies and 26,976 non-diabetic adults. Insulin resistance measured by HOMA-IR is associated with cardiovascular and all-cause mortality; fasting insulin taken alone does not reach significance. The authors consider this last result fragile, given the small number of included studies. | ||||
| Xun P. et al. | 2013 | Meta-analysis | American Journal of Clinical Nutrition | View on PubMed |
Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies Meta-analysis of prospective cohorts showing that elevated fasting insulin is associated with increased risk of hypertension and coronary events. | ||||
| Dankner R. et al. | 2012 | Cohort Study | Diabetes/Metabolism Research and Reviews | View on PubMed |
Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up 24-year follow-up showing that basal hyperinsulinemia in normoglycemic adults is an independent risk factor for future dysglycemia. | ||||
| Wiebe N et al. | 2022 | Cohort Study | International Journal of Obesity | View on PubMed |
Associations of body mass index, fasting insulin, and inflammation with mortality: a prospective cohort study NHANES cohort of 12,563 adults followed through the end of 2015. All-cause mortality risk rises continuously with fasting insulin, with no upturn at the low end of the distribution. | ||||
| Lin Z et al. | 2024 | Cohort Study | Diabetes & Metabolism | View on PubMed |
Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: A 25-year cohort study NHANES III cohort of 13,909 adults, median follow-up of 25 years and 5,306 deaths. Fasting insulin is associated with all-cause mortality, in people living with diabetes as in those without. | ||||
| Rozing MP et al. | 2010 | Cohort Study | Journal of the American Geriatrics Society | View on PubMed |
Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study Leiden Longevity Study: 121 offspring of nonagenarian families compared with 113 partners, none living with diabetes. Mean fasting insulin is 5.81 mU/L, versus 6.75 in the partners. | ||||